Search by Drug Name or NDC
NDC 00069-0220-02 Fragmin 12500 [iU]/.5mL Details
Fragmin 12500 [iU]/.5mL
Fragmin is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is DALTEPARIN SODIUM.
MedlinePlus Drug Summary
Dalteparin is used in combination with aspirin to prevent serious or life-threatening complications from angina (chest pain) and heart attacks. Dalteparin is also used to prevent deep vein thrombosis (DVT; a blood clot, usually in the leg), which can lead to pulmonary embolism (PE; a blood clot in the lung), in people who are on bedrest or who are having hip replacement or abdominal surgery. It is also used treat DVT or PE and prevent it from happening again in children one month of age and older, and in adults with DVT or PE who have cancer. Dalteparin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.
Related Packages: 00069-0220-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dalteparin Injection
Product Information
| NDC | 00069-0220 |
|---|---|
| Product ID | 0069-0220_f665f4ce-6b23-4aee-8a87-ab0ef532be5e |
| Associated GPIs | 8310101010E535 |
| GCN Sequence Number | 041432 |
| GCN Sequence Number Description | dalteparin sodium,porcine SYRINGE 12500/0.5 SUBCUT |
| HIC3 | M9K |
| HIC3 Description | HEPARIN AND RELATED PREPARATIONS |
| GCN | 93952 |
| HICL Sequence Number | 007429 |
| HICL Sequence Number Description | DALTEPARIN SODIUM,PORCINE |
| Brand/Generic | Brand |
| Proprietary Name | Fragmin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dalteparin Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 12500 |
| Active Ingredient Units | [iU]/.5mL |
| Substance Name | DALTEPARIN SODIUM |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020287 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-0220-02 (00069022002)
| NDC Package Code | 0069-0220-02 |
|---|---|
| Billing NDC | 00069022002 |
| Package | 10 SYRINGE in 1 CARTON (0069-0220-02) / .5 mL in 1 SYRINGE (0069-0220-01) |
| Marketing Start Date | 2015-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |